SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : The thread of life -- Ignore unavailable to you. Want to Upgrade?

To: Mike McFarland who wrote (217)9/18/2001 9:47:28 PM
From: SpekulatiusRead Replies (1) | Respond to of 1336
 
Bought some more VRTX, MLNM,MEDX and CRGN today - the former three have made me a lot of trading money in the past and I expect them to do so again.
I also bought the ugly ducks TTP and PRCS again. PRCS near cash value assigns zero value to Abarelix and Latranal. If Abarelix bombs, I figure PRCS should still be worth 5$/share or more, their technology is sort of validated, with a drug making it to PhIII.
TTP is much alike, the market assigns zero value to iloperidone but chances of approval should be at least 50%, IMO.



To: Mike McFarland who wrote (217)9/27/2001 11:18:59 PM
From: Mike McFarlandRespond to of 1336
 
<airline>
Oh yeah, the airline. I decided to dump it and
wait for even cheaper shares.

Bungle of the week: Bought Global Crossing at $3.
f*!


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News